CD36 c.1328_1331dup:一种导致血小板CD36缺乏的变异及其在中国人群中的频率。

IF 1.8 4区 医学 Q3 HEMATOLOGY
Vox Sanguinis Pub Date : 2025-04-22 DOI:10.1111/vox.70034
Lilan Li, Guoguang Wu, Liyang Liang, Jierun Chen, Lihong Jiang, Zhoulin Zhong, Yan Zhou, Justin Wu
{"title":"CD36 c.1328_1331dup:一种导致血小板CD36缺乏的变异及其在中国人群中的频率。","authors":"Lilan Li, Guoguang Wu, Liyang Liang, Jierun Chen, Lihong Jiang, Zhoulin Zhong, Yan Zhou, Justin Wu","doi":"10.1111/vox.70034","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and objectives: </strong>CD36 encodes glycoprotein CD36, with variants causing reduced or absent protein expression. A CD36 variant leading to platelet CD36 deficiency was identified in a Chinese male blood donor, and its molecular basis and population distribution were studied.</p><p><strong>Materials and methods: </strong>Exons 3-14 of the CD36 gene from the identified variant were analysed using Sanger sequencing. CD36 complementary DNA (cDNA) was cloned and sequenced, and a eukaryotic cell line expressing the variant CD36 cDNA transcript was established to assess its protein expression using Western blotting (WB) and flow cytometry (FCM). A genotyping assay was developed and used to type 600 random individuals from Guangxi, China, for the variant.</p><p><strong>Results: </strong>Molecular analysis identified that the subject carries a heterozygous CD36 variant, c.1328_1331dup; p.Glu445Aspfs*65, and expressed both the variant (c.1328_1331dup) and wild-type CD36 messenger RNA (mRNA) transcripts. WB and FCM confirmed that the eukaryotic cell line expressing the CD36 c.1328_1331dup variant failed to produce the CD36 protein. The incidence of the CD36 variant in Guangxi was 0.33% with an allele frequency of 0.001667.</p><p><strong>Conclusion: </strong>This study identified a CD36 variant, c.1328_1331dup; p.Glu445Aspfs*65, responsible for platelet CD36 deficiency, which is present in 0.33% of the Guangxi population.</p>","PeriodicalId":23631,"journal":{"name":"Vox Sanguinis","volume":" ","pages":""},"PeriodicalIF":1.8000,"publicationDate":"2025-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"CD36 c.1328_1331dup: A variant causing platelet CD36 deficiency and its frequency in the Chinese population.\",\"authors\":\"Lilan Li, Guoguang Wu, Liyang Liang, Jierun Chen, Lihong Jiang, Zhoulin Zhong, Yan Zhou, Justin Wu\",\"doi\":\"10.1111/vox.70034\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background and objectives: </strong>CD36 encodes glycoprotein CD36, with variants causing reduced or absent protein expression. A CD36 variant leading to platelet CD36 deficiency was identified in a Chinese male blood donor, and its molecular basis and population distribution were studied.</p><p><strong>Materials and methods: </strong>Exons 3-14 of the CD36 gene from the identified variant were analysed using Sanger sequencing. CD36 complementary DNA (cDNA) was cloned and sequenced, and a eukaryotic cell line expressing the variant CD36 cDNA transcript was established to assess its protein expression using Western blotting (WB) and flow cytometry (FCM). A genotyping assay was developed and used to type 600 random individuals from Guangxi, China, for the variant.</p><p><strong>Results: </strong>Molecular analysis identified that the subject carries a heterozygous CD36 variant, c.1328_1331dup; p.Glu445Aspfs*65, and expressed both the variant (c.1328_1331dup) and wild-type CD36 messenger RNA (mRNA) transcripts. WB and FCM confirmed that the eukaryotic cell line expressing the CD36 c.1328_1331dup variant failed to produce the CD36 protein. The incidence of the CD36 variant in Guangxi was 0.33% with an allele frequency of 0.001667.</p><p><strong>Conclusion: </strong>This study identified a CD36 variant, c.1328_1331dup; p.Glu445Aspfs*65, responsible for platelet CD36 deficiency, which is present in 0.33% of the Guangxi population.</p>\",\"PeriodicalId\":23631,\"journal\":{\"name\":\"Vox Sanguinis\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":1.8000,\"publicationDate\":\"2025-04-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Vox Sanguinis\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1111/vox.70034\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vox Sanguinis","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/vox.70034","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景和目的:CD36编码糖蛋白CD36,其变异导致蛋白表达减少或缺失。在中国男性献血者中发现一种导致血小板CD36缺失的CD36变异,并对其分子基础和人群分布进行了研究。材料和方法:采用Sanger测序法对鉴定的CD36基因外显子3-14进行分析。克隆CD36互补DNA (cDNA)并测序,建立表达CD36变异cDNA转录物的真核细胞系,采用Western blotting (WB)和流式细胞术(FCM)检测其蛋白表达。开发了一种基因分型方法,并将其用于中国广西600名随机个体的变异分型。结果:分子分析发现受试者携带CD36杂合变异c.1328_1331dup;p.Glu445Aspfs*65,表达了突变(c.1328_1331dup)和野生型CD36信使RNA (mRNA)转录本。WB和FCM证实,表达CD36 c.1328_1331dup变异体的真核细胞系不能产生CD36蛋白。广西地区CD36变异发生率为0.33%,等位基因频率为0.001667。结论:本研究鉴定出一种CD36变异,c.1328_1331dup;p.g u445aspfs *65,导致血小板CD36缺乏症,在广西人群中存在0.33%。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
CD36 c.1328_1331dup: A variant causing platelet CD36 deficiency and its frequency in the Chinese population.

Background and objectives: CD36 encodes glycoprotein CD36, with variants causing reduced or absent protein expression. A CD36 variant leading to platelet CD36 deficiency was identified in a Chinese male blood donor, and its molecular basis and population distribution were studied.

Materials and methods: Exons 3-14 of the CD36 gene from the identified variant were analysed using Sanger sequencing. CD36 complementary DNA (cDNA) was cloned and sequenced, and a eukaryotic cell line expressing the variant CD36 cDNA transcript was established to assess its protein expression using Western blotting (WB) and flow cytometry (FCM). A genotyping assay was developed and used to type 600 random individuals from Guangxi, China, for the variant.

Results: Molecular analysis identified that the subject carries a heterozygous CD36 variant, c.1328_1331dup; p.Glu445Aspfs*65, and expressed both the variant (c.1328_1331dup) and wild-type CD36 messenger RNA (mRNA) transcripts. WB and FCM confirmed that the eukaryotic cell line expressing the CD36 c.1328_1331dup variant failed to produce the CD36 protein. The incidence of the CD36 variant in Guangxi was 0.33% with an allele frequency of 0.001667.

Conclusion: This study identified a CD36 variant, c.1328_1331dup; p.Glu445Aspfs*65, responsible for platelet CD36 deficiency, which is present in 0.33% of the Guangxi population.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Vox Sanguinis
Vox Sanguinis 医学-血液学
CiteScore
4.40
自引率
11.10%
发文量
156
审稿时长
6-12 weeks
期刊介绍: Vox Sanguinis reports on important, novel developments in transfusion medicine. Original papers, reviews and international fora are published on all aspects of blood transfusion and tissue transplantation, comprising five main sections: 1) Transfusion - Transmitted Disease and its Prevention: Identification and epidemiology of infectious agents transmissible by blood; Bacterial contamination of blood components; Donor recruitment and selection methods; Pathogen inactivation. 2) Blood Component Collection and Production: Blood collection methods and devices (including apheresis); Plasma fractionation techniques and plasma derivatives; Preparation of labile blood components; Inventory management; Hematopoietic progenitor cell collection and storage; Collection and storage of tissues; Quality management and good manufacturing practice; Automation and information technology. 3) Transfusion Medicine and New Therapies: Transfusion thresholds and audits; Haemovigilance; Clinical trials regarding appropriate haemotherapy; Non-infectious adverse affects of transfusion; Therapeutic apheresis; Support of transplant patients; Gene therapy and immunotherapy. 4) Immunohaematology and Immunogenetics: Autoimmunity in haematology; Alloimmunity of blood; Pre-transfusion testing; Immunodiagnostics; Immunobiology; Complement in immunohaematology; Blood typing reagents; Genetic markers of blood cells and serum proteins: polymorphisms and function; Genetic markers and disease; Parentage testing and forensic immunohaematology. 5) Cellular Therapy: Cell-based therapies; Stem cell sources; Stem cell processing and storage; Stem cell products; Stem cell plasticity; Regenerative medicine with cells; Cellular immunotherapy; Molecular therapy; Gene therapy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信